The prevalence of dyslipidemia is high and increasing in many developing countries, including Saudi Arabia because of the westernization of diet and other lifestyle changes.
Introduction
Dyslipidemias are disorders of lipoprotein metabolism, including lipoprotein overproduction or deficiency. These disorders may be manifested by elevation of the serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglyceride concentrations, and a decrease in the high-density lipoprotein cholesterol (HDL-C) concentration. It is the major risk factor for coronary heart disease (CHD), the leading cause of deaths worldwide. [1] Treatment with cholesterol-lowering drugs appears to be accompanied by a reduction in the lipid content of atherosclerotic plaques, thereby making them more stable and less prone to rupture, [2] it can also reduce the risk of heart disease by 30% over a 5-year period. [3] Although the benefits of lipidlowering therapy have been demonstrated most conclusively in patients with cardiovascular disease, lipid-lowering therapy is effective even in patients without clinically apparent cardiovascular disease. [4] The World Health Organization (WHO) estimates that dyslipidemia is associated with more than half of the global cause of ischemic heart diseases. [5] A meta-analysis of 38 primary and secondary prevention trials showed that for every 10% reduction in plasma TC, CHD mortality is reduced by 15% and total mortality risk by 11%. [6] The prevalence of dyslipidemia is high and increasing in most developed countries [7] as well as in many developing countries because of the westernization of diet and other lifestyle changes. [8] A study carried out in Saudi Arabia reported that an overall prevalence of dyslipidemia ranged from approximately 20% to 40%. The highest prevalence was for triglycerides where approximately 44% of all participants were affected. About a fifth of the participants had high level of TC. Men had significantly higher prevalence of all types of dyslipidemia than women except LDL-C and TC. [9] This study was carried out to estimate the prevalence and to identify the associated factors of dyslipidemia among Saudi employees in the primary health care in Jeddah City.
Materials and Methods
A retrospective cross-sectional study was conducted among primary health care employees in Jeddah, Saudi Arabia. According to the geographic distribution, seven primary health care centers were randomly selected. Sample of 416 employees' medical files were taken in to consideration. This study is limited to the Saudi employees whose age ranged from 20 to 60 years.
Data were collected over a period of 3 months from June 2014 to August 2014. Extracted data were recorded on the data collection sheet developed by the researcher. The data sheet was designed to collect demographic characteristics of the patients such as age, gender, height, weight, lipid profile results, and blood glucose levels.
Anthropometric measurements, including weight and height were obtained. Weight was measured by using Detecto Physician Medical Body Weight Scale -400 lb. Capacity with Height Rod was measured to the nearest centimeter using a stadiometer with the shoulder in a relaxed position and the arms hanging freely. Body mass index (BMI) was calculated as the ratio of weight (kilograms) to the square of height (meters).
For laboratory analysis and all biochemical measurements, two sets of fasting blood samples were drawn from a cannula inserted into the antecubital vein, one to the sodium fluoride potassium oxalate tubes for glucose tests and the other to lithium heparin vacuum tubes for lipid tests. Fasting plasma glucose was measured by the glucose oxidase method with the help of a Cobas Analyzer (Roche) USA. TC, HDL-C, LDL-C, and triglycerides were assayed by the automated spectrophotometer and enzymatic colorimetric method with the help of Cobas Integra (Roche).
Operational Definitions
BMI: It is classified according to the following WHO criteria [10] : normal when BMI is 24.9≤kg/m 2 , overweight when BMI is 25-29.9 kg/m 2 , and obese when BMI is ≥30 kg/m 2 . Blood pressure: Hypertension was defined if the patient was already on antihypertensive drugs, or if the blood pressure was higher than 140 mm Hg systolic and/or higher than 90 mm Hg diastolic. [11] Dyslipidemia: It was defined according to the NCEP ATPIII: National Cholesterol Education Program's Adult Treatment Panel criteria 2003, [12] if one or more of the follo wing are found: total serum cholesterol >200 mg/dL, serum LDL >130 mg/dL in patients with diabetes. LDL >100 mg/dL, serum triglyceride >150 mg/dL, and serum HDL <40 mg/dL in men, and <50 mg/dL in women. The patients were also diagnosed to have dyslipidemia if they were on medication for any of the above conditions.
Smoking: According to WHO guidelines, [13] current smoker is defined as a person who smokes cigarettes daily or occasionally, past-smoker is a person who was formerly a daily or occasional smoker, but currently does not smoke at all, and nonsmoker is a person who has never smoked before or has smoked very little in the past. Prediabetes [14] : It was defined when Fasting blood sugar (FBS) (≥100 and <126 mg/dL). Fasting is defined as no caloric intake for at least 8 hours overnight. Diabetes [14] : It was defined when FBS (≥126 mg/dL).
Statistical Analysis
The statistical program SPSS version 22 was used for data collection and statistical analysis. In univariate analysis, continuous variables will be analyzed as mean ± standard deviation and categorical variables as frequencies and percentages. Crude odds ratio (OR) and related 95% confidence interval (CI) were used and results were considered significant at a p-value of <0.05. Multivariate analysis using binary logistic regression analysis was applied to determine risk factors after controlling for confounders.
Result
This study included 416 employees, 145 (34.9%) men and 271(65.1%) women. The mean age was 38.1 ± 9.3 years. The prevalence of smoking was 24.5%. The prevalence of overweight and obesity was 35.0% and 30.7%, respectively. Slightly more than one-third of them (37.9%) were at least university graduated [ Table 1 ].
As shown in Table 2 , the prevalence of dyslipidemia was 78%. The prevalence of high TC was 38.7%. The prevalence of high LDL and low HDL was 43.5% and 45.2%, respectively. The prevalence of high triglyceride was 17.4%. The prevalence of hypertension was 20% whereas the prevalence of Diabetes mellitus (DM) was 22.1%. The prevalence of pre-DM was 18.6%.
Participants aged 40 years or older were more likely to have dyslipidemia compared with those younger than 40 years (crude OR = 13.44; 95% CI: 2.96-61.11). Patients who were hypertensive were almost at an eightfold risk to have dyslipidemia compared with those with normal blood pressure (crude OR = 8.09; 95% CI: 2.62-24.95). Patients with diabetes were almost at a tenfold risk to develop dyslipidemia compared with nondiabetics (crude OR = 10.73; 95% CI: 1.94-77.84). Patients with ischemic heart diseases were at higher risk to develop dyslipidemia as opposed to those without such history (crude OR = 11.0; 95% CI: 2.01-60.23).
Other factors (age, gender, smoking, BMI, education, and family history of hypertension, diabetes mellitus, and ischemic heart disease) were not significant risk factors for dyslipidemia [ Table 3 ].
Multivariate logistic regression analysis revealed that patients with hypertension were almost at an 11-fold risk to have dyslipidemia compared with those with normal blood pressure (crude OR = 10.85; 95% CI: 2.32-26.31, p = 0.024). Patients with diabetes were almost at a ninefold risk to develop dyslipidemia compared with nondiabetics (crude OR = 9.27; 95% CI: 1.68-52.19, p = 0.019). Age and history of ischemic heart diseases were not proved to be predictors of dyslipidemia.
Discussion
The prevalence of dyslipidemia is rising over time in developing countries. [15] It is one of the confirmed potential risk factors for cardiovascular diseases in the same category with other high-risk factors, such as diabetes, hypertension, and cigarette smoking.
As documented in this study, the prevalence of dyslipidemia among primary health care employees in Jeddah, Saudi Arabia was very high (78%). Our finding is considered very high compared with other findings. In another study conducted in Saudi Arabia, [16] the overall prevalence of all types of dyslipidemia was ranged from approximately 20% to 44%. The highest prevalence was for triglycerides, where approximately 44% of all participants were affected. Even lower rates have been reported by others. [17] [18] [19] [20] Several studies worldwide reported that the rates of dyslipidemia ranged from 2.7% to 51.9%. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] This relatively large range in recent years may be due to socioeconomic status, genetic races, or differences in definitions, methodologies, and study populations.
In this study, patients with hypertension were more prone to dyslipidemias compared with those who were normotensives. This finding is in accordance with those reported by others. [31] [32] [33] It has been documented that an increase in dyslipidemia may contribute to other complications of hypertension and may also cause higher mortality because of CVD. [31] Several studies demonstrated significant association between dyslipidemia and BMI. [31, 34] In disagreement with those studies, this study did not confirm a significant association between BMI and dyslipidemia.
The metabolic disturbances including disturbed glucose, dyslipidemia, and hypertension are often concurrent and are strongly associated with the subsequent development of CVD, [30] with insulin resistance being the most important common mechanisms. [35] In this survey, diabetes was a significant risk factor for dyslipidemia.
Among limitations of this study is the non inclusion of dietary factors as possible associated factors with dyslipidemia. Another important limitation is cross-sectional design in our study, which could only reflect associations between dyslipidemia and risk factors and not causality. Finally, we depended on BMI only for definition of obesity, thus abdominal obesity was not considered.
Conclusion
Conclusively, this study demonstrated a very high prevalence of dyslipidemia, which showed an alarming rise since the publication of our previous study and other similar studies around the world. In the light of our study results, we recommended conduction of screening studies of dyslipidemia in all primary care health employees in Jeddah. Terms of age and history of ischemic heart diseases were removed from the final model.
